Higher urinary IgM excretion in type 2 diabetic nephropathy compared to type 1 diabetic nephropathy.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Kidney International

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1046/J.1523-1755.2002.00108.XPMID 11786102
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Literature abstracts

  2004cited by this paper
• Nephropathy in Patients with Type 2 Diabetes

  2002cited by this paper
• Glomerular permselectivity in early stages of overt diabetic nephropathy.

  2000cited by this paper
• A modern approach to selectivity of proteinuria and tubulointerstitial damage in nephrotic syndrome.

  2000cited by this paper
• Excerpts from United States Renal Data System 1999 Annual Data Report.

  1999cited by this paper
• Urine IgG2/IgG4-ratio indicates the significance of the charge selective properties of the glomerular capillary wall for the macromolecular transport in glomerular diseases.

  1999cited by this paper
• Glomerular size-selective dysfunction in NIDDM is not ameliorated by ACE inhibition or by calcium channel blockade.

  1999cited by this paper
• Nephropathy in patients with type 2 diabetes mellitus.

  1999cited by this paper
• Size-selectivity of the glomerular barrier to high molecular weight proteins: upper size limitations of shunt pathways.

  1998cited by this paper
• Proteinuria selectivity index based upon alpha 2-macroglobulin or IgM is superior to the IgG based index in differentiating glomerular diseases. Technical note.

  1998cited by this paper
• Preliminary description of focal segmental glomerulosclerosis in patients with renovascular disease.

  1996cited by this paper
• Analysis of proteinuria: reference limits for urine excretion of albumin, protein HC, immunoglobulin G, k- and Δ-immunoreactivity, orosomucoid and α1-antitrypsin

  1996cited by this paper
• Renal findings in patients with short-term type 2 diabetes.

  1996cited by this paper
• Analysis of proteinuria: reference limits for urine excretion of albumin, protein HC, immunoglobulin G, kappa- and lambda-immunoreactivity, orosomucoid and alpha 1-antitrypsin.

  1996cited by this paper
• Progression of overt nephropathy in non-insulin-dependent diabetes.

  1995cited by this paper
• Transport of macromolecules across microvascular walls: the two-pore theory.

  1994cited by this paper
• A prospective study of blood pressure and serum creatinine. Results from the 'Clue' Study and the ARIC Study.

  1993cited by this paper
• Glomerular clearance and tubular reabsorption of IgG1 and IgG4 in microalbuminuric patients with non-insulin-dependent diabetes mellitus (NIDDM).

  1993cited by this paper
• Pre-diabetic blood pressure predicts urinary albumin excretion after the onset of Type 2 (non-insulin-dependent) diabetes mellitus in Pima Indians

  1993cited by this paper
• A Prospective Study of Blood Pressure and Serum Creatinine: Results From the 'Clue' Study and the ARIC Study

  1993cited by this paper
• Selectivity of the glomerular filtration barrier in healthy and nephrotic humans.

  1993cited by this paper
• The physiological and pathophysiological basis of glomerular permeability for plasma proteins and erythrocytes.

  1992cited by this paper
• Tubulointerstitial changes as a major determinant in the progression of renal damage.

  1992cited by this paper
• Triphasic Changes in Selectivity with Increasing Proteinuria in Type 1 and Type 2 Diabetes

  1989cited by this paper
• Heteroporous model of glomerular size selectivity: application to normal and nephrotic humans.

  1985cited by this paper
• Light-Scattering Immunoassay of Specific Proteins: A Review

  1983cited by this paper
• The renal circulation in essential hypertension.

  1983cited by this paper
• A review of transcapillary fluid and solute exchange in the renal glomerulus.

  1980cited by this paper
• Macromolecule transport across glomerular capillaries: application of pore theory.

  1979cited by this paper
• Prediction of Creatinine Clearance from Serum Creatinine

  1976cited by this paper
• Human gene mapping 3. Baltimore Conference (1975). Third International Workshop on Human Gene Mapping. Report of the committee on the genetic constitution of autosomes other than chromosomes 1, 2, and 6.

  1976cited by this paper
• Prediction of creatinine clearance from serum creatinine.

  1975cited by this paper
• Filtration, diffusion and molecular sieving through peripheral capillary membranes; a contribution to the pore theory of capillary permeability.

  1951cited by this paper

• Elevated homocysteine contributes to the progression of type 1 diabetic nephropathy: Evidence from Mendelian randomization and experimental validation

  2026cites this paper
• Update on the Pathogenesis, Diagnosis, and Treatment of Diabetic Tubulopathy

  2024cites this paper
• Assessment of Responsiveness to No Treatment (ther. 0), Treatment with Steroids and Cyclophosphamide (ther. 2), Treatment with Steroids Alone (ther. 3) in 177 Patients with Glomerulonephritis and Nephrotic Syndrome (NS)

  2023cites this paper
• GP73 blockade alleviates abnormal glucose homeostasis in diabetic mice.

  2022cites this paper
• Diabetic kidney disease treatment: new perspectives

  2022cites this paper
• Novel biomarkers for diabetic kidney disease

  2022cites this paper
• Novel biomarkers for prognosticating diabetic kidney disease progression

  2022cites this paper
• The effect of angiotensin II on diabetic glomerular hyperpermeability: In vivo permeability studies in rats.

  2020cites this paper
• Diet and postprandial risk markers for complications in type 2 diabetes

  2020cites this paper
• Urinary IgM excretion: a reliable marker for adverse pregnancy outcomes in women with chronic kidney disease

  2018cites this paper
• Urinary N‐acetyl‐β‐glucosaminidase and estimated Glomerular filtration rate may identify patients to be treated with immuno‐suppression at diagnosis in idiopathic membranous nephropathy

  2018cites this paper
• The Clinical Impact of Glomerular Immunoglobulin M Deposition in Patients with Type 2 Diabetic Nephropathy

  2018cites this paper
• A Study on Biomarkers in a Spatially Distributed Type – 2 Diabetes mellitus Groups in Southern Tamil Nadu, India

  2017cites this paper
• Biomarkers of diabetic nephropathy: A 2017 update

  2017cites this paper
• The association between urinary lgM excretion and diabetic retinopathy in diabetic patients

  2016influential citation
• Urinary N-acetyl-β-glucosaminidase and eGFR may identify patients to be treated with immuno-suppression at diagnosis in idiopathic membranous nephropathy.

  2016cites this paper
• Prediction of ESRD and long-term remission by proteinuric markers in Primary Focal Segmental Glomerulosclerosis with Nephrotic Syndrome : a review

  2016cites this paper
• Novel Biomarkers for Early Diagnosis and Progression of Diabetic Nephropathy

  2016cites this paper
• Monoclonal Antibody Pharmacokinetics in Type 2 Diabetes Mellitus and Diabetic Nephropathy

  2016cites this paper
• The role of metformin in the prevention of diabetic nephropathy in experimental type 2 diabetes

  2016cites this paper
• Proteinuric Biomarkers in Chronic Kidney Disease

  2016cites this paper
• Proteases and Protease Inhibitors of Urinary Extracellular Vesicles in Diabetic Nephropathy

  2015cites this paper
• Effect of Type 2 Diabetes Mellitus and Diabetic Nephropathy on IgG Pharmacokinetics and Subcutaneous Bioavailability in the Rat

  2015cites this paper
• Tubular reabsorption of high, middle and low molecular weight proteins according to the tubulo-interstitial damage marker N-acetyl-β-d-glucosaminidase in glomerulonephritis

  2015cites this paper
• Urinary biomarkers for early diabetic nephropathy in type 2 diabetic patients

  2015cites this paper
• Reduced glomerular size selectivity in late streptozotocin-induced diabetes in rats: application of a distributed two-pore model

  2015cites this paper
• An Extended Minimal Physiologically Based Pharmacokinetic Model: Evaluation of Type II Diabetes Mellitus and Diabetic Nephropathy on Human IgG Pharmacokinetics in Rats

  2015cites this paper
• Impact of Diseases, Comorbidity, and Target Physiology on ADME, PK, and PK/PD of Therapeutic Biologics

  2015cites this paper
• Investigation of the Influence of Nephropathy on Monoclonal Antibody Disposition: A Pharmacokinetic Study in a Mouse Model of Diabetic Nephropathy

  2014cites this paper
• Potential urinary biomarkers of acute kidney injury in domestic animals

  2014cites this paper
• Assessment of Urinary Osteopontin in Association with Podocyte for Early Predication of Nephropathy in Diabetic Patients

  2014cites this paper
• Urinary Biomarkers and Patient Outcome in Chronic Kidney Disease and Atherosclerotic Heart Disease: The value of IgM-uria and IgG-uria

  2014cites this paper
• Proteinuria: pathophysiology, diagnostic and therapeutic approach

  2013cites this paper
• New urinary biomarkers for diabetic kidney disease

  2013cites this paper
• Association Between Urinary IgG and Relative Risk for Factors Affecting Proteinuria in Type 2 Diabetic Patients

  2012cites this paper
• Urinary Markers of Glomerular Injury in Diabetic Nephropathy

  2012cites this paper
• Elevated urinary excretion of immunoglobulins in nonproteinuric patients with type 1 diabetes.

  2012cites this paper
• Increased Urine IgM and IgG2 Levels, Indicating Decreased Glomerular Size Selectivity, Are Not Affected by Dalteparin Therapy in Patients with Type 2 Diabetes

  2012cites this paper
• Proteinuria: From Molecular to Clinical Applications in Glomerulonephritis

  2012cites this paper
• Urine IgM-excretion as a prognostic marker for progression of type 2 diabetic nephropathy.

  2012influential citation
• Selective targeting of melanoma by PEG-masked protein-based multifunctional nanoparticles

  2012cites this paper
• Analysis of affinity maps of membrane proteins on individual human embryonic stem cells.

  2011cites this paper
• The response to antihypertensive therapy is dependent on renal structural changes. A 5-year prospective study of renal biopsy in type 2 diabetic patients with micro-macroalbuminuria.

  2010cites this paper
• Increased urine IgM excretion predicts cardiovascular events in patients with type 1 diabetes nephropathy

  2009cites this paper
• The ratio between kidney volume and function increases with the progression of nephropathy in Type 2 diabetes.

  2009cites this paper
• Decreased urinary concentration of Tamm–Horsfall protein is associated with development of renal failure and cardiovascular death within 20 years in type 1 but not in type 2 diabetic patients

  2008cites this paper
• Profiling TRA-1-81 antigen distribution on a human embryonic stem cell.

  2008cites this paper
• Stretched photonic suspension array for label-free high-throughput assay

  2008cites this paper
• Diagnóstico de la leishmaniosis críptica en el perro. Expresión isotípica e idiotípica de los anticuerpos producidos en distintas fases de la infección

  2007cites this paper
• Urine IgM excretion predicts outcome in ANCA-associated renal vasculitis.

  2006cites this paper
• ZO-1 expression and phosphorylation in diabetic nephropathy.

  2006cites this paper
• Pathophysiology of proteinuria.

  2003cites this paper
• Detection of Anti-Leishmania Immunoglobulin G Antibodies in Urine Specimens of Dogs with Leishmaniasis

  2003cites this paper
• Nephrology

  2001cites this paper
• PERSPECTIVES IN BASIC SCIENCE Pathophysiology of proteinuria

  year unknowninfluential citation